AVIR
$25.11
Atea Pharmaceuticals
($.42)
(1.65%)
AVIR
Earnings Whisper ®
N/A
2nd Quarter June 2021
Consensus:  $0.01
Revenue:  $57.99 Mil
Thursday
Aug 12
4:05 PM ET
Score
Grade
Tweet Share Watch
Tweet Share Watch

What do you expect when AVIR reports earnings?
Beat
Meet
Miss

Where is AVIR's stock price going from here?
Up
Flat
Down
Stock chart of AVIR
Analysts
Summary of analysts' recommendations for AVIR
Score
Grade
Pivots
Resistance
$26.89
$26.39
$25.75

$25.25

Support
$24.61
$24.11
$23.47
Tweet
Growth
Description
Atea Pharmaceuticals Inc. is a clinical-stage biopharmaceutical company. It is focused on discovering, developing and commercializing antiviral therapeutics to improve the lives of patients suffering from life-threatening viral infections. Atea Pharmaceuticals Inc. is based in BOSTON.